Overview

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Status:
Completed

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

This is a phase II study comparing the effects of lapatinib versus placebo when administered concurrently with cisplatin and radiotherapy followed by 1 year monotherapy with lapatinib or placebo. The study is designed to evaluate and compare the two treatment groups with respect to complete response rate at 6 months following chemoradiation completion.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Cisplatin
Lapatinib